Efficacy of liquid biopsy for genetic mutations determination in non-small cell lung cancer: a systematic review on literatures

被引：0
|
作者：
Mohammad Mehdi Jahani [1 ]
Parisa Mashayekhi [2 ]
Mir Davood Omrani [1 ]
Azita Azimi Meibody [5 ]
机构：
[1] Shahid Beheshti University of Medical Sciences,Department of Medical Genetics
[2] Pasteur Institute of Iran,Molecular Medicine Department, Biotechnology Research Center
[3] Isfahan University of Medical Sciences,Department of Emergency Medicine, Faculty of Medicine
[4] Isfahan University of Medical Sciences,Department of Health in Disaster and Emergencies, Faculty of Management and Medical Information
[5] Shahid Beheshti University of Medical Sciences,Urogenital Stem Cell Research Center, Research Institute for Urology and Nephrology, Shahid Labbafinejad Medical Center
来源：
BMC Cancer | / 25卷 / 1期
关键词：
Non-small cell lung cancer; Liquid biopsy; Digital droplet PCR; Next-generation sequencing; EGFR mutations; CtDNA; Personalized therapy;
D O I：
10.1186/s12885-025-13786-w
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] BRAF Mutations in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Chen, Dong
    Zhang, Li-Qun
    Huang, Jun-Fu
    Liu, Kai
    Chuai, Zheng-Ran
    Yang, Zhao
    Wang, Yun-Xia
    Shi, Da-Chuan
    Liu, Qian
    Huang, Qing
    Fu, Wei-Ling
    PLOS ONE, 2014, 9 (06):
  • [22] A systematic review of targeted agents for non-small cell lung cancer
    Vestergaard, Hannah H.
    Christensen, Marcus R.
    Lassen, Ulrik N.
    ACTA ONCOLOGICA, 2018, 57 (02) : 176 - 186
  • [23] Gender Disparities in Non-Small Cell Lung Cancer: A Systematic Review
    Alsaadoun, Noor
    Kopciuk, Karen
    Hao, Desiree
    Riabowol, Karl
    Hollenbrg, Morley Hollenberg
    Bebb, Gwyn
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S352 - S353
  • [24] Liquid biopsy: Safety and efficacy in a tool for molecular profiling of advanced non-small cell lung cancer (NSCLC).
    Rizwan, Saleha
    Otaibi, Zachary
    Lo, Herman
    Khan, Talal
    Wegner, Rodney E.
    Finley, Gene Grant
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] BRAF mutations in non-small cell lung cancer
    Luk, Peter P.
    Yu, Bing
    Ng, Chiu Chin
    Mercorella, Belinda
    Selinger, Christina
    Lum, Trina
    Kao, Steven
    O'Toole, Sandra A.
    Cooper, Wendy A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (02) : 142 - 148
  • [26] RAS gene mutations and their prevalence in non-small Cell lung cancer : A Review
    Alharthi, Siraj B.
    Tayeb, Islam M.
    Pascual, Romar
    Aloufi, Salman
    Mutabbaqani, Rasha A.
    Alharthi, Dalia
    Al-bariqi, Ahmed S.
    Almutiri, Basem J.
    Alsulaiman, Abdullah S.
    BIOSCIENCE RESEARCH, 2022, 19 (02): : 1139 - 1147
  • [27] BRAF Mutations and Resistance of Non-Small Cell Lung Cancer to BRAF-Targeted Therapies Using Liquid Biopsy
    Li, Ming
    Zhang, Xiaoying
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2021, 8 (02) : 110 - 111
  • [28] Sputum supernatant as a viable liquid biopsy in advanced non-small cell lung cancer
    Zhou, C.
    Xie, X.
    Wu, J.
    Guo, B.
    Qin, Y.
    Lin, X.
    Liu, M.
    Qiu, L.
    Xiang, J.
    Chen, Z.
    Zou, X.
    ANNALS OF ONCOLOGY, 2021, 32 : S994 - S994
  • [29] The era of a "liquid biopsy" may be on the horizon in non-small cell lung cancer Preface
    Tartarone, Alfredo
    JOURNAL OF THORACIC DISEASE, 2017, 9 : S1322 - S1322
  • [30] Role of liquid biopsy in oncogene-addicted non-small cell lung cancer
    Canale, Matteo
    Pasini, Luigi
    Bronte, Giuseppe
    Delmonte, Angelo
    Cravero, Paola
    Crino, Lucio
    Ulivi, Paola
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S265 - S279
12345